The latest closing stock price for Summit Therapeutics as of September 18, 2024 is 24.56.
An investor who bought $1,000 worth of Summit Therapeutics stock at the IPO in 2015 would have $1,410 today, roughly 1 times their original investment - a 9.20% compound annual growth rate over 10 years.
The all-time high Summit Therapeutics stock closing price was 31.93 on September 13, 2024.
The Summit Therapeutics 52-week high stock price is 33.89, which is 38% above the current share price.
The Summit Therapeutics 52-week low stock price is 1.64, which is 93.3% below the current share price.
The average Summit Therapeutics stock price for the last 52 weeks is 5.77.
An investor who bought $1,000 worth of Summit Therapeutics stock at the IPO in 2015 would have $1,410 today, roughly 1 times their original investment - a 9.20% compound annual growth rate over 10 years.
The all-time high Summit Therapeutics stock closing price was 31.93 on September 13, 2024.
The Summit Therapeutics 52-week high stock price is 33.89, which is 38% above the current share price.
The Summit Therapeutics 52-week low stock price is 1.64, which is 93.3% below the current share price.
The average Summit Therapeutics stock price for the last 52 weeks is 5.77.